Allergan Acquires EndoArt

Allergan Inc. (NYSE:AGN) has acquired EndoArt SA, a Swiss provider of remote-controlled implants used in the treatment of morbid obesity and other conditions. The deal is valued at $97 million in cash. EndoArt had raised over $13 million in VC funding since spinning out from the Swiss Federal Institute of Technology in 1998, from firms like TAT Capital Partners, Sofinnova Partners, Genevest, Vinci Capital, Venture Incubator AG and EMBL Venture Capital. www.allergan.com www.endoart.com